Thursday, May 24, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
The best of both
In January 2007, Merck Serono was launched as a subsidiary of Merck KGaA.
No Comments
Minimising human error
“Human error is the most expensive productivity inhibitor - RFID-Technology helps to minimise error rates in laboratories”
No Comments
Advantages of Automated Cell Culture using CELLSTAR® AutoFlask™
Dr. Lara Marchetti, Product Manager R&D - Cell Culture Products
No Comments
Pandemic preparedness
In April 2007, the FDA announced the first approval in the US of a vaccine for humans against the H5N1 influenza virus. Its manufacturer, sanofi pasteur, does not intend to sell this vaccine to private markets but only to governments; and it is already developing newer ones.
No Comments
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.